/Zoetis%20Inc%20HQ%20sign-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Parsippany, New Jersey-based Zoetis Inc. (ZTS) discovers, develops, and commercializes animal health medicines, vaccines, and diagnostic products and services. With a market cap of $75.4 billion, Zoetis operates as the largest producer of medicine and vaccines for pets and livestock in the world, with operations spanning over 100 countries in North America, Europe, and internationally.
The healthcare giant is set to announce its fourth-quarter results before the market opens on Thursday, Feb. 13. Ahead of the event, analysts expect ZTS to report a non-GAAP profit of $1.38 per share, up 11.3% from $1.24 per share reported in the year-ago quarter. While the company has surpassed Wall Street’s bottom-line projections in three of the past four quarters, it has missed the estimates on one other occasion.